Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 study to assess the safety, tolerability, and pharmacokinetics of ABSK-021 in patients with advanced solid tumors. The study includes Tenosynovial Giant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors
• Tenosynovial Giant Cell Tumor

Drugs mentioned

• ABSK-021

Snippet

Sponsor: Abbisko Therapeutics Co, Ltd | Conditions: Neoplasms, Tenosynovial Giant Cell Tumor | Phase 1 | Status: RECRUITING